TCF-1 Is Required for CD4 T Cell Persistence Functions During AlloImmunity

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Mar 11

PMID 36901757

Authors

Mahinbanu Mammadli

Liye Suo

Jyoti Misra Sen

Mobin Karimi

Affiliations

Soon will be listed here.

Abstract

The transcription factor T cell factor-1 (TCF-1) is encoded by Tcf7 and plays a significant role in regulating immune responses to cancer and pathogens. TCF-1 plays a central role in CD4 T cell development; however, the biological function of TCF-1 on mature peripheral CD4 T cell-mediated alloimmunity is currently unknown. This report reveals that TCF-1 is critical for mature CD4 T cell stemness and their persistence functions. Our data show that mature CD4 T cells from TCF-1 cKO mice did not cause graft versus host disease (GvHD) during allogeneic CD4 T cell transplantation, and donor CD4 T cells did not cause GvHD damage to target organs. For the first time, we showed that TCF-1 regulates CD4 T cell stemness by regulating CD28 expression, which is required for CD4 stemness. Our data showed that TCF-1 regulates CD4 effector and central memory formation. For the first time, we provide evidence that TCF-1 differentially regulates key chemokine and cytokine receptors critical for CD4 T cell migration and inflammation during alloimmunity. Our transcriptomic data uncovered that TCF-1 regulates critical pathways during normal state and alloimmunity. Knowledge acquired from these discoveries will enable us to develop a target-specific approach for treating CD4 T cell-mediated diseases.

Citing Articles

High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC.

Forde D, Kilvaer T, Pedersen M, Blix E, Urbarova I, Paulsen E Front Immunol. 2025; 15:1504220.

PMID: 39749327 PMC: 11693705. DOI: 10.3389/fimmu.2024.1504220.

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.

Talvard-Balland N, Braun L, Dixon K, Zwick M, Engel H, Hartmann A J Clin Invest. 2024; 134(16).

PMID: 38916965 PMC: 11324309. DOI: 10.1172/JCI177460.

mA inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC/PD-L1 signaling.

Li S, Feng T, Liu Y, Yang Q, Song A, Wang S Int J Oral Sci. 2024; 16(1):36.

PMID: 38730256 PMC: 11087574. DOI: 10.1038/s41368-024-00304-0.

Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT.

Harris R, Karimi M Front Immunol. 2023; 14:1194984.

PMID: 37441063 PMC: 10333690. DOI: 10.3389/fimmu.2023.1194984.

CD4 T cell memory is impaired by species-specific cytotoxic differentiation, but not by TCF-1 loss.

Hofland T, Danelli L, Cornish G, Donnarumma T, Hunt D, de Carvalho L Front Immunol. 2023; 14:1168125.

PMID: 37122720 PMC: 10140371. DOI: 10.3389/fimmu.2023.1168125.

References

Abraham K, Teale J . The contribution of parasite-specific T cells to isotype restriction in Mesocestoides corti-infected mice. J Immunol. 1987; 139(8):2530-7. View

Glinos D, Soskic B, Williams C, Kennedy A, Jostins L, Sansom D . Genomic profiling of T-cell activation suggests increased sensitivity of memory T cells to CD28 costimulation. Genes Immun. 2020; 21(6-8):390-408. PMC: 7785515. DOI: 10.1038/s41435-020-00118-0. View

Bleakley M, Turtle C, Riddell S . Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation. Expert Rev Hematol. 2012; 5(4):409-25. PMC: 3590108. DOI: 10.1586/ehm.12.28. View

Jiang H, Fu D, Bidgoli A, Paczesny S . T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor. Front Immunol. 2021; 12:761448. PMC: 8525316. DOI: 10.3389/fimmu.2021.761448. View

Oestreich K, Huang A, Weinmann A . The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J Exp Med. 2011; 208(5):1001-13. PMC: 3092354. DOI: 10.1084/jem.20102144. View

Coghill J, Sarantopoulos S, Moran T, Murphy W, Blazar B, Serody J . Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new. Blood. 2011; 117(12):3268-76. PMC: 3069668. DOI: 10.1182/blood-2010-12-290403. View

Raphael I, Joern R, Forsthuber T . Memory CD4 T Cells in Immunity and Autoimmune Diseases. Cells. 2020; 9(3). PMC: 7140455. DOI: 10.3390/cells9030531. View

Bastien J, Roy J, Roy D . Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation. Semin Oncol. 2012; 39(6):674-82. DOI: 10.1053/j.seminoncol.2012.09.004. View

Zaph C, Rook K, Goldschmidt M, Mohrs M, Scott P, Artis D . Persistence and function of central and effector memory CD4+ T cells following infection with a gastrointestinal helminth. J Immunol. 2006; 177(1):511-8. PMC: 1805702. DOI: 10.4049/jimmunol.177.1.511. View

10.

Fanelli G, Romano M, Nova-Lamperti E, Sunderland M, Nerviani A, Scotta C . PD-L1 signaling on human memory CD4+ T cells induces a regulatory phenotype. PLoS Biol. 2021; 19(4):e3001199. PMC: 8101994. DOI: 10.1371/journal.pbio.3001199. View

11.

Scott A, Dundar F, Zumbo P, Chandran S, Klebanoff C, Shakiba M . TOX is a critical regulator of tumour-specific T cell differentiation. Nature. 2019; 571(7764):270-274. PMC: 7698992. DOI: 10.1038/s41586-019-1324-y. View

12.

Yu X, Liang Y, Nurieva R, Guo F, Anasetti C, Dong C . Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells. J Immunol. 2006; 176(12):7394-401. DOI: 10.4049/jimmunol.176.12.7394. View

13.

Beilhack A, Schulz S, Baker J, Beilhack G, Wieland C, Herman E . In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005; 106(3):1113-22. PMC: 1895168. DOI: 10.1182/blood-2005-02-0509. View

14.

Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M . The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal. 2017; 15(1):23. PMC: 5480189. DOI: 10.1186/s12964-017-0177-y. View

15.

Seo H, Chen J, Gonzalez-Avalos E, Samaniego-Castruita D, Das A, Wang Y . TOX and TOX2 transcription factors cooperate with NR4A transcription factors to impose CD8 T cell exhaustion. Proc Natl Acad Sci U S A. 2019; 116(25):12410-12415. PMC: 6589758. DOI: 10.1073/pnas.1905675116. View

16.

Teshima T . Th1 and Th17 join forces for acute GVHD. Blood. 2011; 118(18):4765-7. DOI: 10.1182/blood-2011-09-377325. View

17.

Xu L, Cao Y, Xie Z, Huang Q, Bai Q, Yang X . The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection. Nat Immunol. 2015; 16(9):991-9. DOI: 10.1038/ni.3229. View

18.

Yuan X, Dong Y, Tsurushita N, Tso J, Fu W . CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms. JCI Insight. 2018; 3(2). PMC: 5821175. DOI: 10.1172/jci.insight.96600. View

19.

Mohty M, Gaugler B . Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation. Cytokine Growth Factor Rev. 2007; 19(1):53-63. DOI: 10.1016/j.cytogfr.2007.10.010. View

20.

Nishimura R, Baker J, Beilhack A, Zeiser R, Olson J, Sega E . In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. Blood. 2008; 112(6):2563-74. PMC: 2532819. DOI: 10.1182/blood-2007-06-092817. View